BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32696884)

  • 1. Effects of four types of integrated Chinese and Western medicines for the treatment of COVID-19 in China: a network meta-analysis.
    Jin L; Xu Y; Yuan H
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):771-777. PubMed ID: 32696884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis.
    Zhang X; Cao D; Liu J; Zhang Q; Liu M
    Medicine (Baltimore); 2020 Jul; 99(30):e21404. PubMed ID: 32791754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis.
    Liu M; Gao Y; Yuan Y; Yang K; Shi S; Zhang J; Tian J
    Pharmacol Res; 2020 Aug; 158():104896. PubMed ID: 32438037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019.
    Wang DC; Yu M; Xie WX; Huang LY; Wei J; Lei YH
    J Integr Med; 2022 Jan; 20(1):26-33. PubMed ID: 34782291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials.
    Zeng M; Li L; Wu Z
    PLoS One; 2020; 15(9):e0238828. PubMed ID: 32915877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
    Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
    Zhang Q; Cao F; Ji G; Xu X; Sun Y; Li J; Qi X; Sun S; Wang Y; Song B
    Medicine (Baltimore); 2020 Jul; 99(30):e20979. PubMed ID: 32791675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research.
    Wang J; Qi F
    Drug Discov Ther; 2020; 14(3):149-150. PubMed ID: 32669523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic efficacy of Chinese patent medicine combined with routine western medicine in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis.
    Zhang J; Li S; Zhao C; Wang W; Li F; Li F
    Medicine (Baltimore); 2020 Sep; 99(38):e22277. PubMed ID: 32957380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019].
    Gu M; Liu J; Shi NN; Li XD; Huang ZD; Wu JK; Wang YG; Wang YP; Zhai HQ; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1253-1258. PubMed ID: 32281333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
    Zhang YS; Cong WH; Zhang JJ; Guo FF; Li HM
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1263-1271. PubMed ID: 32281335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of traditional Chinese medicine combined with routine western medicine for the asymptomatic novel coronavirus disease (COVID-19): A Bayesian network meta-analysis protocol.
    Wang J; Zhu X; Sun Y; Zhang X; Zhang W
    Medicine (Baltimore); 2020 Aug; 99(35):e21927. PubMed ID: 32871931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta analysis on the treatment of coronavirus disease 2019 by traditional Chinese and Western medicine].
    Wang Q; Mei J; Wang C; Wu L; Gao H; Zhang H; Chen F
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):714-720. PubMed ID: 34296692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19.
    Jiang S; Cui Q; Ni B; Chen Y; Tan Y; Chen W; Chen YZ
    Pharmacol Res; 2020 Sep; 159():104989. PubMed ID: 32502638
    [No Abstract]   [Full Text] [Related]  

  • 15. [Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
    Li WF; Hu CC; Ding YL; Yuan B
    Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4505-4516. PubMed ID: 36046880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).
    Huang YF; Bai C; He F; Xie Y; Zhou H
    Pharmacol Res; 2020 Aug; 158():104939. PubMed ID: 32445956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of medication regularity and pharmacodynamic characteristics of traditional Chinese medicine treatment in 444 severe cases of COVID-19].
    Wang C; Ming H; Jia W; Su W; Zhan LR; Luo D; Yang JY
    Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(13):3007-3012. PubMed ID: 32726005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traditional Chinese Medicine treatment of COVID-19.
    Xu J; Zhang Y
    Complement Ther Clin Pract; 2020 May; 39():101165. PubMed ID: 32379692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining].
    Fan T; Chen Y; Bai Y; Ma F; Wang H; Yang Y; Chen J; Lin Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(2):260-269. PubMed ID: 32391675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.